Featured Research

from universities, journals, and other organizations

Common Anesthetics Appear Safe For Developing Fetal Brain

Date:
March 21, 2005
Source:
Duke University Medical Center
Summary:
An anesthetic regimen commonly used during surgery on pregnant mothers appears to have no negative effects on the developing brain of the fetus, according to a new study on sheep conducted by Duke University Medical Center researchers.

DURHAM, N.C. – An anesthetic regimen commonly used during surgery on pregnant mothers appears to have no negative effects on the developing brain of the fetus, according to a new study on sheep conducted by Duke University Medical Center researchers.

Furthermore, the researchers found, the use of this regimen to produce general anesthesia appears to improve the oxygenation of the fetal brain, according to their novel system for measuring cerebral oxygenation in the developing fetus.

These findings are an important step toward better understanding this issue, the researchers said, since a study in new-born rats published in 2003 reported that exposure to various anesthetic agents caused neurodegeneration in the developing rat brain. However, the Duke researchers said that the current study may be more realistic, since it is was conducted under circumstances that more closely parallel that which humans would experience.

"The results of this investigation suggest that the moderate inhalation anesthetic exposure during pregnancy may not be deleterious to the fetus," said lead researcher James D. Reynolds, Ph.D., research director of women's anesthesia at Duke. The results of the Duke study were published March 9, 2005, as an advanced on-line publication of the Journal of Cerebral Blood Flow and Metabolism.

"These types of studies are very difficult to conduct in humans, since you can't do the invasive type of monitoring you can in animal models, and it is difficult to separate the effects of the anesthesia from the underlying reasons for the surgery," Reynolds said. "So we felt that in order to come as close as possible to what might be expected in humans, we had to do something new."

General anesthesia, which typically involves a combination of drugs, renders the patients temporarily unconscious during the surgery.

The earlier study -- the results of which led to much discussion in the anesthesia community -- involved putting newborn rat pups in a static chamber, where they inhaled various anesthetics. The results of those studies showed evidence of increased apoptosis, or programmed cell death, in developing nerve cells.

For their new experiments, the Duke team developed a model using pregnant sheep. When the sheep fetus was approximately 17 weeks old – an age that approximates a third-trimester human pregnancy – the researchers exposed the mother to a three-drug anesthetic combination commonly used to produce general anesthesia. The exposures lasted four hours, a length of time that would encompass most surgeries conducted on pregnant patients.

"We found that four hours of maternal general anesthesia produced an initial increase in systematic oxygenation in the fetus, as well as a sustained increase in oxygenation in the brain," Reynolds said.

The researchers could document cerebral oxygenation in real time because of a system they optimized for fetal applications. The technique, called near-infrared spectroscopy, was originally conceived in the 1970s by Duke faculty member Franz Jobsis.

Light in the near-infrared range can easily pass through skin, bone and other tissues. However, within these frequencies of light, the oxygen-carrying molecules within red blood cells known as hemoglobin absorb light to an extent based on their oxygen content -- giving the researchers a reliable indicator of cerebral oxygenation. Researchers place a fiberoptic probe against the skull of the fetus to measure the changing oxygenation levels of blood circulating in the brain, Reynolds said.

Reynolds said that the increase in oxygenation in the fetal brain is likely due to isoflurane, one of the three commonly used agents, which induced reductions in oxygen metabolism along with increases in cerebral blood flow. Isoflurane is known to produce these actions in the adult brain but it had not been appreciated that such effects could also occur in the fetal brain, he said.

Besides the oxygenation studies, the researchers also examined the brain tissue from the exposed fetuses and found no evidence of neurodegeneration or apoptosis.

The researchers said the timing of the exposures to anesthetic agents is an important consideration when determining how closely animal models reflect what may occur in humans. The brains of different animals, as well as humans, are more vulnerable to insult at different times in their development.

"Most of the major synapse formation and neuronal development of the rat is a post-natal event, peaking at about day seven after birth," Reynolds said. "In sheep however, the brain growth spurt occurs toward the end of gestation, which in many respects is more similar to what happens in humans, where development occurs both before and after birth."

Reynolds said that since it is ethically questionable and technically difficult to do exposure studies directly in humans, large retrospective epidemiological studies are needed to determine whether there are any cognitive or development issues in children or young adults whose mothers received general anesthesia for surgery.

The most common surgeries that pregnant human mothers undergo are abdominal, such as appendectomies or gall bladder removals, Reynolds said. These procedures are more common in women than men, and they can be especially difficult to accurately diagnose in pregnant women, since many of the symptoms of these disorders are similar to those of pregnancy.

Reynolds said that the laboratory's future investigations will focus on determining the upper limits of anesthetic exposure, as well as developing a better understanding of the combined effects of anesthesia and surgical manipulation on physiological changes in the fetus. His research group is also investigating the effects of the gases used to "inflate" the abdomen to enable the use of minimally invasive laparoscopic procedures.

The research was support by the National Institutes of Health, the Howard Hughes Medical Institute, the Duke Anesthesiology Research Fund and the Duke Endosurgery Center.

Other members of the research team are Rebecca McClaine, Sebastian de la Fuente, Roberto Manson, John Booth, William White, Kurt Campbell1, Deborah McClaine, all of Duke; Kenichiro Uemura, Hiroshima University, Japan; Paul Benni, CAS Medical Inc.; and Steve Eubanks, formerly of Duke and now chair of the Department of Surgery at the University of Missouri.


Story Source:

The above story is based on materials provided by Duke University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Duke University Medical Center. "Common Anesthetics Appear Safe For Developing Fetal Brain." ScienceDaily. ScienceDaily, 21 March 2005. <www.sciencedaily.com/releases/2005/03/050309101759.htm>.
Duke University Medical Center. (2005, March 21). Common Anesthetics Appear Safe For Developing Fetal Brain. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/03/050309101759.htm
Duke University Medical Center. "Common Anesthetics Appear Safe For Developing Fetal Brain." ScienceDaily. www.sciencedaily.com/releases/2005/03/050309101759.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins